{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:51:58Z","timestamp":1787611918261,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Inflammatory responses in the peritoneum contribute to peritoneal dialysis (PD)-associated peritoneal fibrosis. Results of our previous study showed that increased microsomal prostaglandin E synthase-1-mediated production of prostaglandin E2 (PGE2) contributed to peritoneal fibrosis. However, the role of its downstream receptor in the progression of peritoneal fibrosis has not been established. Here, we examined the role of PGE2 receptor 4 (EP4) in the development of peritoneal fibrosis. EP4 was significantly upregulated in peritoneal tissues of PD patients with ultrafiltration failure, along with the presence of an enhanced inflammatory response. <jats:italic>In vitro<\/jats:italic> experiments showed that exposure to high glucose concentrations enhanced EP4 expression in rat peritoneal mesothelial cells (RPMCs). High-glucose\u2013induced expression of inflammatory cytokines (monocyte chemoattractant protein-1, tumour necrosis factor \u03b1, and interleukin 1\u03b2) was significantly reduced in RPMCs treated with ONO-AE3-208, an EP4 receptor antagonist. ONO-AE3-208 also significantly decreased the expression of extracellular matrix proteins induced by high glucose concentrations. Furthermore, ONO-AE3-208 blunted activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome and phosphorylation of nuclear factor kappa B (NF-\u03baB) (p-p65). To further investigate the functional role of EP4, ONO-AE3-208 was administrated for 4\u00a0weeks in a rat model of PD, the results of which showed that ONO-AE3-208 inhibited peritoneal fibrosis and improved peritoneal dysfunction. Additionally, inflammatory cytokines in the peritoneum of PD rats treated with ONO-AE3-208 were downregulated, in line with inhibition of the NLRP3 inflammasome and NF-\u03baB phosphorylation. In conclusion, an EP4 antagonist reduced the development of peritoneal fibrosis, possibly by suppressing NLRP3 inflammasome- and p-p65\u2013mediated inflammatory responses. Our findings suggest that an EP4 antagonist may be therapeutically beneficial for PD-associated peritoneal fibrosis.<\/jats:p>","DOI":"10.3389\/fphar.2022.1004619","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T06:08:35Z","timestamp":1668146915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qimei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianrui","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"F1869","DOI":"10.1152\/ajprenal.00113.2018","article-title":"Blockade of prostaglandin E(2) receptor 4 ameliorates nephrotoxic serum nephritis","volume":"315","author":"Aringer","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1681\/asn.2008020211","article-title":"Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane","volume":"20","author":"Aroeira","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Cao","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4049\/jimmunol.177.1.681","article-title":"Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2\/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B","volume":"177","author":"Chen","year":"2006","journal-title":"J. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1476-5381.2010.00647.x","article-title":"A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models","volume":"160","author":"Chen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3389\/fphys.2017.00762","article-title":"Proinflammatory effect of high glucose concentrations on HMrSV5 cells via the autocrine effect of HMGB1","volume":"8","author":"Chu","year":"2017","journal-title":"Front. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2013.02.027","article-title":"Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis","volume":"421","author":"de Lima","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12233","DOI":"10.1073\/pnas.0915112107","article-title":"Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis","volume":"107","author":"Esaki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-007-0541-z","article-title":"Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis","volume":"23","author":"Fusshoeller","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1161\/atvbaha.120.314297","article-title":"Excessive EP4 signaling in smooth muscle cells induces abdominal aortic aneurysm by amplifying inflammation","volume":"40","author":"Hiromi","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1476-5381.2009.00317.x","article-title":"Prostanoid receptor antagonists: Development strategies and therapeutic applications","volume":"158","author":"Jones","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nm872","article-title":"Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells","volume":"9","author":"Kabashima","year":"2003","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1177\/089686080702702s12","article-title":"Mediators of inflammation and fibrosis","volume":"27","author":"Lai","year":"2007","journal-title":"Perit. Dial. Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.kint.2020.02.012","article-title":"The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo","volume":"98","author":"Lannoy","year":"2020","journal-title":"Kidney Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/biolre\/ioy162","article-title":"PGE2 increases inflammatory damage in Escherichia coli-infected bovine endometrial tissue in vitro via the EP4-PKA signaling pathway","volume":"100","author":"Li","year":"2019","journal-title":"Biol. Reprod."},{"key":"B16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cellbi.2006.11.018","article-title":"A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells","volume":"31","author":"Liu","year":"2007","journal-title":"Cell. Biol. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3747\/pdi.2014.00188","article-title":"Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?","volume":"35","author":"Liu","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"675363","DOI":"10.3389\/fmed.2021.675363","article-title":"Enhanced mPGES-1 contributes to PD-related peritoneal fibrosis via activation of the NLRP3 inflammasome","volume":"8","author":"Luo","year":"2021","journal-title":"Front. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00210-018-01600-3","article-title":"Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5\/6 nephrectomized chronic kidney disease rats","volume":"392","author":"Mizukami","year":"2019","journal-title":"Naunyn. Schmiedeb. Arch. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/labinvest.2013.85","article-title":"Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6","volume":"93","author":"Mohamed","year":"2013","journal-title":"Lab. Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1681\/asn.2014090939","article-title":"Interstitial fibrosis restricts osmotic water transport in encapsulating peritoneal sclerosis","volume":"26","author":"Morelle","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41556-021-00708-8","article-title":"E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis","volume":"23","author":"Patankar","year":"2021","journal-title":"Nat. Cell. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"97843","DOI":"10.1172\/jci.insight.97843","article-title":"Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice","volume":"3","author":"Rahman","year":"2018","journal-title":"JCI Insight"},{"key":"B24","doi-asserted-by":"publisher","first-page":"F198","DOI":"10.1152\/ajprenal.00293.2012","article-title":"Isolation of interstitial fluid and demonstration of local proinflammatory cytokine production and increased absorptive gradient in chronic peritoneal dialysis","volume":"304","author":"Rosengren","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3389\/fmicb.2018.02447","article-title":"PGE2 augments inflammasome activation and M1 polarization in macrophages infected with Salmonella typhimurium and Yersinia enterocolitica","volume":"9","author":"Sheppe","year":"2018","journal-title":"Front. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"724141","DOI":"10.3389\/fphar.2021.724141","article-title":"Blockade of autophagy prevents the development and progression of peritoneal fibrosis","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1681\/asn.v9112005","article-title":"High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity","volume":"9","author":"Sitter","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/FJC.0b013e3182244a12","article-title":"Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases","volume":"59","author":"Tang","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000368972","article-title":"Ultrafiltration failure in peritoneal dialysis: A pathophysiologic approach","volume":"39","author":"Teitelbaum","year":"2015","journal-title":"Blood Purif."},{"key":"B31","doi-asserted-by":"publisher","first-page":"695933","DOI":"10.3389\/fimmu.2021.695933","article-title":"Myeloid-derived suppressor cells dampen airway inflammation through prostaglandin E2 receptor 4","volume":"12","author":"van Geffen","year":"2021","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/hypertensionaha.114.03654","article-title":"Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla","volume":"64","author":"Wang","year":"2014","journal-title":"Hypertension"},{"key":"B33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.1968","article-title":"Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion","volume":"15","author":"Yao","year":"2009","journal-title":"Nat. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","article-title":"Preventing peritoneal membrane fibrosis in peritoneal dialysis patients","volume":"90","author":"Zhou","year":"2016","journal-title":"Kidney Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajpath.2013.05.019","article-title":"miR-30a negatively regulates TGF-\u03b21-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1","volume":"183","author":"Zhou","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1159\/000478070","article-title":"Activation of COX-2\/mPGES-1\/PGE2 cascade via NLRP3 inflammasome contributes to albumin-induced proximal tubule cell injury","volume":"42","author":"Zhuang","year":"2017","journal-title":"Cell. Physiol. biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10760","DOI":"10.1038\/ncomms10760","article-title":"Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality","volume":"7","author":"Zoccal","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1004619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T06:08:37Z","timestamp":1668146917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1004619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":37,"alternative-id":["10.3389\/fphar.2022.1004619"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1004619","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"article-number":"1004619"}}